Patient advocacy organizations and research investigators can now take advantage of a new integrated registry and repository resource to further advance rare disease research.
read moreCoriell Institute for Medical Research, the largest biobank of living human cells, is partnering with IBM to advance its research of human genetic disease and to more efficiently maintain its massive collection of biological resources.
read moreCoriell Institute for Medical Research has embarked on a partnership with Ohio State University Medical Center physicians to incorporate genetic risk information into their patients’ electronic medical records, through their participation in the Coriell Personalized Medicine Collaborative (CPMC) research study.
read moreCoriell Institute for Medical Research announced today the availability of powerful new stem cells to the scientific research community. These cells – called induced pluripotent stem cells – possess many of the important properties of embryonic stem cells. However, they bypass controversy as they can be made from skin cells or blood cells, avoiding the need to involve embryo-derived cells.
read moreCoriell Institute for Medical Research announced a partnership today in which Ohio State University Medical Center physicians are incorporating genetic risk information into their patients’ electronic medical records, through their participation in the Coriell Personalized Medicine Collaborative (CPMC) research study.
read moreClose on the heels of another major award from the National Institutes of Health (NIH), the Coriell Institute has announced its receipt of a five-year, $6-million NIH contract to manage the National Institute on Aging (NIA) Aging Cell Repository.
read moreFollowing a nationwide competition, the Coriell Institute for Medical Research today announced its receipt of a five-year, $27 million National Institute of General Medical Sciences (NIGMS) Human Genetic Cell Repository award through the National Institutes of Health.
read more